A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

Clinical trial NCT05726864 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05726864
Sponsor: Elicio Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Colorectal Cancer KRAS G12D KRAS G12R KRAS G12V KRAS G12A KRAS G12C KRAS G12S KRAS G13D NRAS G12D NRAS G12R NRAS G12V

Start date: 2023-04-14
Primary completion: 2026-04-20
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.